Idera's Hep C Drug Put on Hold
A Hepatitis C Phase 2 trial for Idera's IMO-2125 has been halted due to preliminary data linking the drug to cancerous growth in lab rats.
Continue reading »Research & Treatment News
Share
Follow Us
Phase III Trials Begin for Boehringer's Hepatitis C Drug
May 3, 2011
1 Comment
Enrolling 1,875 patients with chronic genotype-1 Hepatitis C, Boehringer will begin three phase III trials for BI 201335, an oral protease inhibitor.
Continue reading »Hepatitis B Drug Resistance
Find out why chronic Hepatitis B treatment is continually challenged by the virus's potential to mutate and become drug resistant.
Continue reading »Seven Tips to Boost HCV Therapy Adherence
A successful Hepatitis C treatment outcome hinges on medication adherence. Review these seven tips for improving treatment adherence to maximize your chance of beating this virus.
Continue reading »IL28B Diagnostic Test Now Widely Available
Available to physicians, other healthcare providers and drug companies for research purposes, Quest Diagnostics now offers a test to identify IL28B - the genetic variant that helps predict responsiveness to interferon-based therapy for Hepatitis C.
Continue reading »Should You Include Coconut Oil in Your Hep C Wellness Plan?
Apr 20, 2011
11 Comments
Possessing attributes that could benefit someone with chronic Hepatitis C, discover why coconut oil consumption is not necessarily an ideal dietary staple.
Continue reading »Are Early Menopause and Hepatitis C Treatment Response Connected?
Compared to women in their childbearing years, menopausal women have a disadvantage in the battle against Hepatitis C. However, those who begin menopause prematurely have an even greater hurdle to overcome.
Continue reading »Encouraging News for Hepatitis C Vaccine
Preliminary phase I data for a therapeutic T-cell Hepatitis C vaccine posts hopeful results.
Continue reading »Antidepressants Improve Hep C Therapy Adherence
An observational analysis has found that those on antidepressant medications during Hepatitis C treatment are more likely to complete interferon-based therapy.
Continue reading »Telaprevir's Chemistry Speeds HCV Treatment Time
Upon further study of telaprevir, researchers have determined that it may dramatically shorten the time required for successful Hepatitis C therapy.
Continue reading »
